Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
Abstract Interstitial lung disease (ILD), as an adverse effect of certain drugs, leads to inflammation and damage in the walls of the alveoli, making it difficult for the alveoli to take up oxygen. Interstitial pneumonia with no identifiable cause is called idiopathic interstitial pneumonia (IIP), a...
Main Authors: | Hideki Nawa, Hirofumi Hamano, Takahiro Niimura, Koji Miyata, Kenta Yagi, Mitsuhiro Goda, Yoshito Zamami, Keisuke Ishizawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13419 |
Similar Items
-
Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments
by: Hideki Nawa, et al.
Published: (2022-01-01) -
Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage
by: Toshihiko Yoshioka, et al.
Published: (2023-11-01) -
Angiogenesis inhibitor-specific hypertension increases the risk of developing aortic dissection
by: Kaito Tsujinaka, et al.
Published: (2023-11-01) -
Preventive Effects of Quercetin against the Onset of Atherosclerosis-Related Acute Aortic Syndromes in Mice
by: Masateru Kondo, et al.
Published: (2020-09-01) -
Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
by: Atsushi Kumanogoh, et al.
Published: (2023-01-01)